Singapore markets closed

Laboratorio Reig Jofre, S.A. (0RB1.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.5200+0.0200 (+0.80%)
As of 09:01AM BST. Market open.

Laboratorio Reig Jofre, S.A.

Gran Capita, 10
Sant Joan Despí
Barcelona 08970
Spain
34 93 480 67 10
https://www.reigjofre.com

Sector(s)
Industry
Full-time employees1,331

Key executives

NameTitlePayExercisedYear born
Mr. Ignasi Biosca ReigCEO & Executive Director445kN/AN/A
Ms. Roser Gomila ZabalaChief Financial OfficerN/AN/AN/A
Ms. Estefanía RuizGroup Chief Accountant & ControllerN/AN/AN/A
Ms. Victoria SerraManager of Human ResourcesN/AN/AN/A
Mr. Marc RamosHead of Tax & Financial ConsolidationN/AN/AN/A
Mr. Adolf Rousaud ViñasNon-Director SecretaryN/AN/AN/A
Amounts are as of 31 December 2015, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers medical devices, cosmetics, parapharmacy, and animal food related products; and biotechnological and health products. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. In addition, the company provides CDMO and CMO services. It sells its products through business partners. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.

Corporate governance

Laboratorio Reig Jofre, S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.